Clinical Trial Update: A Study of Vorinostat in Patients With Solid Tumors (MK-0683-029) [Phase 1]

View source ↗

Summary

Phase 1 trial update of vorinostat in patients with solid tumors has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor
• Tumor

Drugs mentioned

• Vorinostat (vorinostat)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Tumors | Phase 1 | Status: COMPLETED | Results posted: 2022-05-02